EMERGENT BIODEFENSE OPERATIONS LANSING LLC

Emergent Biodefense Operations Lansing LLC specializes in the manufacturing of advanced biodefense therapeutics and vaccines, with demonstrated expertise in the production of anthrax vaccine adsorbed (BioThrax), a critical component of U.S. military preparedness. The company operates within the medicinal and botanical manufacturing sector, applying rigorous aseptic processing, lyophilization, and biocontainment protocols to produce FDA-licensed biologics under strict GMP standards. Their technical capabilities include antigen purification, adjuvant formulation, sterile fill-finish operations, and end-to-end cold chain logistics for high-consequence pathogens. Differentiators include validated manufacturing scalability for national stockpile requirements and deep familiarity with Department of Defense biological threat countermeasure specifications. The contractor’s primary agency engagement is with the Department of Defense, where it delivers mission-critical medical countermeasures for force protection and biodefense readiness. Work includes end-to-end procurement and supply of licensed vaccines designed for rapid deployment in high-risk operational environments, supporting DoD’s Biomedical Advanced Research and Development Authority (BARDA) and Defense Threat Reduction Agency (DTRA) objectives. Relationships are characterized by repeat, mission-aligned procurements focused on sustaining the Strategic National Stockpile and ensuring readiness against biothreat agents. The company’s industry focus centers on NAICS 325411—Medicinal and Botanical Manufacturing—specifically the production of licensed biologics for infectious disease defense. This vertical specialization places them at the intersection of biopharmaceutical manufacturing and national security, serving a niche market requiring compliance with CDC, FDA, and DoD biological safety and efficacy standards. Their positioning is that of a specialized biodefense manufacturer, not a broad pharmaceutical entity. Emergent Biodefense Operations Lansing LLC is structured as a 2L entity with its primary operations based in Lansing, Michigan. While no federal certifications are listed, its manufacturing processes must meet stringent federal biologics standards, including those outlined in 21 CFR Part 610 and DoD biodefense acquisition directives. The company’s geographic footprint is centralized, with capabilities tailored to support federal biodefense supply chain resilience.